Neuro-Oncology Reviews
Volume
27 Number 26
20 September 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 26, 20 September
Feng J, Yang J.
Glioma-neuron
interactions: insights from neural plasticity.
Front
Oncol. 2025 Sep 11;15:1661897. doi:
10.3389/fonc.2025.1661897. PMID:
41018101. Review. ˍ
Xu W, Xu Q, Luo P, Qu X, Guo D, Xie Z, Hang N, Kuang M, Chen E,
Wang L, Yan Z, Cai S, Mao W, Tang B.
Gut-Brain-Microbiome
Axis in the Regulation of Cancer Immune Escape and Immunotherapy
in Tumors.
Research
(Wash D C). 2025 Sep 11;8:0885. doi:
10.34133/research.0885. PMID:
40948940. Review. ˍ
Zickus JR, Enriquez JS, Smith P, Sun BT, Wang M, Morales A,
Bhattacharya PK, Pudakalakatti S.
NMR-Based
Metabolomic Profiling for Brain Cancer Diagnosis and Treatment
Guidance.
Metabolites.
2025 Sep 11;15(9):607. doi:
10.3390/metabo15090607. PMID:
41002991. Review. ˍ
Seyve A, Ducray F.
Open questions on
vorasidenib.
Curr
Opin Oncol. 2025 Sep 12;37(6):589-594. doi:
10.1097/CCO.0000000000001193. PMID:
41029964. Perspective˰
ˍ
De Sousa-Coelho AL, Solaković B, Bento AD, Fernandes MT.
Drug Repurposing for Targeting Cancer
Stem-like Cells in Glioblastoma.
Cancers
(Basel). 2025 Sep 14;17(18):2999. doi:
10.3390/cancers17182999. PMID:
41008843. Review. ˍ
Barati S, Ghoflchi S, Hosseinzadeh P, Pouramini S, Hosseini H,
Jalili-Nik M.
Promising Cancer Vaccine
for Glioblastoma Therapy: A Focus on mRNA Vaccine.
Cancer
Med. 2025 Sep 15;14(18):e71187. doi:
10.1002/cam4.71187. PMID: 40948290. Review. ˍ
Zhang X, Li Y, Liu N, Zhang Y, Yang N, Zhou L.
Oncolytic
virus therapy for glioma: current clinical trials and overcoming
key obstacles.
Int
Immunopharmacol. 2025 Sep 15;166:115547. doi:
10.1016/j.intimp.2025.115547. PMID:
40957170. Review˰
ˍ
Hernandez MALU, Apor ADAO, Chan KIP, Khu KJO.
Top
100 Most Cited Articles on Awake Glioma Surgery: A Bibliometric
Analysis.
Acta
Med Philipp. 2025 Sep 16;59(13):60-69. doi:
10.47895/amp.v59i13.11080. PMID:
41104057 Bibliometric analysis. ˍ
Goldbrunner R, Foroglou N, Signorelli F, Schucht P, Jakola AS,
Minniti G, Rola R, Renovanz M, Preusser M, Furtner J, Grossman R,
Mawrin C, Demetriades A, Weller M, Simon M.
EANS-EANO
Guidelines on the extent of resection in gliomas.
Neuro
Oncol. 2025 Sep 17:noaf217. doi:
10.1093/neuonc/noaf217. PMID:
40973061. Guidelines˰
ˍ
Moghib K, Hassan MA, Eljadid GY, Salomon I, Algazar MA, Abu Arafeh
MW, Baklola M, Hafez W, Ibrahim IA.
Safety
and efficacy of depatuxizumab mafodotin monotherapy or in
combination with temozolomide in patients with/without
EGFR-amplified recurrent glioblastoma: a systematic review.
Ann
Med Surg (Lond). 2025 Sep 17;87(11):7478-7494. doi:
10.1097/MS9.0000000000003869. PMID:
41180763. Review. ˍ
Yi L, Wang W, Chen Y, Xiong Z, Ma L, Wang Z, Ye W, Li X.
A
bibliometric analysis of global research trends in autophagy and
glioblastomas.
Naunyn
Schmiedebergs Arch Pharmacol. 2025 Sep 17. doi:
10.1007/s00210-025-04578-x. PMID:
40960516. Bibliometric
analysis˰ ˍ
Booth TC, Summers D, Shah J, Bulbeck H, Grant R.
Earlier
diagnosis of patients with brain tumour.
Pract
Neurol. 2025 Sep 18:pn-2025-004768. doi:
10.1136/pn-2025-004768. PMID:
40967900. Editorial. ˍ
Chen J, Wu Q, Berglund AE, Macaulay RJ, Mulé JJ, Etame AB.
Tumor-Associated Macrophages in
Glioblastoma: Mechanisms of Tumor Progression and Therapeutic
Strategies.
Cells.
2025 Sep 18;14(18):1458. doi:
10.3390/cells14181458. PMID:
41002423. Review. ˍ
Sathe S, Li Q, Jung J, Wu J.
Targeting
the Mitochondria in High-Grade Gliomas.
Cancers
(Basel). 2025 Sep 19;17(18):3062. doi:
10.3390/cancers17183062. PMID:
41008904. Review. ˍ